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In the pharmaceutical setting, it is often necessary to establish the shelf life of a 
drug product and sometimes suitable to assess the risk of product failure at the desired 
expiry period. The current statistical methodology use confidence intervals for the 
predicted mean to establish the expiry period and prediction intervals for a predicted new 
assay value or a tolerance interval for a proportion of the population for use in a risk 
assessment. A major concern is that most methodology treat a homogeneous 
subpopulation, say batch, either as a fixed effect and therefore uses a fixed-effects 
regression model (Graybill, 1976) or as a mixed-effects model limited to balanced data 
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structures (Jonsson, 2003). However, batch is definitely a random effect as this fact has 
been reflected by some recent methodology [Altan, Cabrera and Shoung (2005), Hoffman 
and Kringle (2005)]. Thus, to assess the risk of product failure at expiry, it is necessary to 
use tolerance intervals since they provide an estimate of the proportion of assay values 
and/or batches failing at the expiry period. In this thesis, we illustrate the methodology 
described by Jonsson (2003) to construct β-expectation tolerance limits for longitudinal 
data in a random-effects setting. We underline the limitations of Jonsson’s approach to 
constructing tolerance intervals and highlight the need for a better methodology. 
 
1 
1 Introduction 
 
1.1. Introduction to Interval Estimates 
Scientists and engineers frequently express the need to quantify the uncertainty 
associated with a point estimate in order to make decisions from limited sample data. 
They may wish to obtain more data prior to making a decision if their knowledge of the 
uncertainty is imprecise. To quantify such uncertainty, interval estimates are constructed 
around a point estimate. Three different types of interval estimates may be calculated 
from sampled data. Depending upon the type of application, the analyst may choose a 
confidence interval, a tolerance interval, or a prediction interval.  
Using sample data, some researchers may be interested in estimating a confidence 
interval, a range of values expected to encompass the population parameter of interest 
with some specified level of confidence. One way to think about confidence intervals is 
to consider drawing many samples (in the same manner) from a population. Each sample 
yields its own estimate of the parameter of interest (e.g., the population mean) and 
corresponding confidence interval with a selected or desired confidence coefficient (e.g., 
95%). In this repeated sense, approximately 95% of the confidence intervals will enclose 
the population mean.  
Similar to the confidence interval, a tolerance interval is a range of values 
expected to contain a certain percentage of observations from a population on the 
average. For example, one may be interested in determining a range of values expected to 
encompass 90% of the population on the average.  
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Confidence intervals and tolerance intervals are both interval estimates for 
parameters of the population. A prediction interval is a range of values expected to 
encompass a new (future) observation from the population with a specified level of 
confidence. For example, one may be interested in determining a range of values 
containing the next predicted value with 95% confidence. 
In order to choose the most appropriate interval (confidence, tolerance, or 
prediction), the analyst must decide whether the main interest of the application resides in 
describing the population from which the sample has been selected or in predicting the 
results of a future sample from the same population.  
 
1.2. Motivation 
In the pharmaceutical setting, it is often necessary to establish the expiry period of 
a drug and sometimes suitable to assess the risk of product failure at the desired expiry 
period. The Food and Drug Administration (FDA) guidelines (FDA, 1987) requires that a 
minimum of three batches be tested in stability analysis to account for batch-to-batch 
variability so that a single shelf life is applicable to all future batches manufactured under 
similar circumstances. In addition to the estimation of the individual shelf life for each 
batch, it is also desirable to establish a single shelf life for a drug product based on 
combined stability data from all batches. The FDA guidelines requires that preliminary 
tests of batch similarity be performed before combining the stability data from all 
batches. A test for differences in the intercepts and differences in the slopes of 
degradation lines among different batches is performed to evaluate batch similarity. The 
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FDA recommends the 0.25 level of significance to test these hypotheses. Thus, the 
single shelf life can be determined, based on the ordinary least-squares methods, as the 
time point at which the 95% lower confidence bound for the mean degradation curve of 
the drug characteristic intersects the approved lower specification limit. 
If the hypotheses of equal intercepts and equal slopes are not rejected at the 0.25 
level of significance, a single expiration dating period is usually estimated by fitting a 
single degradation curve based on the pooled stability data of all batches under the 
assumption that batch effects are fixed. If the hypotheses of equal intercepts and equal 
slopes are rejected at the 0.25 level of significance, the FDA recommends determining a 
single expiration dating period of the drug product based on the minimum of shelf lives 
obtained from each batch. However, Chow and Shao (1991) showed that this method had 
no statistical justification since the minimum approach is conservative and does not take 
into account batch-to-batch variability.  
Confidence intervals for the predicted mean are commonly used to establish the 
expiry period of a drug product. Prediction intervals for a predicted new assay value and 
tolerance intervals for a proportion of the population are sometimes used in risk 
assessment. To assess the risk of product failure at expiry, it is more appropriate to use 
tolerance intervals since they provide an interval estimate for the proportion of assay 
values in the population failing at the expiry period.  
The need for tolerance intervals was greatly emphasized during the first half of 
the twentieth century. Wilks (1942) defined and constructed tolerance limits in the case 
of normal distribution with unknown mean and variance. The use of tolerance intervals 
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based on linear models became the interest of various researchers such as Wallis (1951), 
Weissberg and Beatty (1960), Lieberman and Miller (1963), Ellison (1964), Howe 
(1969), Graybill (1976). A procedure for establishing a two-sided tolerance interval based 
on a balanced mixed-effects model was proposed by Liao and Iyer (2004). Under the 
assumption of fixed batch effects, Hsu and Ruberg (1992) proposed a method to estimate 
the expiration dating period of a drug product by using multiple comparison technique for 
pooling stability data with the worst batch. The foregoing methodology (fixed batch 
effects model) assumes that the drug characteristic decreases linearly over time. The 
comparison of regression lines necessitates not only a test of equality of intercepts and 
equality of slopes but also the equivalence of within batch variability. It should be 
recognized, however, that the between-batch variation is often ignored during the 
decision making process for pooling stability data across batches. 
The FDA guidelines indicate that the batches used in long-term stability studies 
for the establishment of drug shelf life should constitute a random sample from the 
population of future production batches. The FDA also requires that all estimated 
expiration dating periods should be applicable to all future batches. Under these 
assumptions, the statistical methods derived from the fixed-effects models may not be 
appropriate. This is due to the fact that statistical inferences about the expiration dating 
period obtained from a fixed-effects model can only be drawn from the batches under 
study and cannot necessarily be applied to future or unobserved batches. The use of 
statistical methods based on a random-effects model is therefore more appropriate for 
establishing the expiration dating period for future production batches. Several 
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researchers have gained interest in the use of tolerance intervals in random-effects 
settings. Lemon (1977) and Mee and Owen (1983) considered the case of one-sided 
tolerance intervals for balanced one-way random-effects models. This was soon followed 
by an extension to the unbalanced random-effects model [see Bhaumick and Kulkarni 
(1991,1996), Bagui et al. (1996)]. Two-sided tolerance intervals for balanced one-way 
random-effects models were also considered by Mee (1984) and an extension for 
unbalanced data was described by Beckman and Tietjen (1989) and Wang and Iyer 
(1994). The computation of a one-sided tolerance limit for a one-way random-effects 
model for both balanced and unbalanced data using the concept of a generalized 
confidence interval explored by Weerahandi (1993, 1995) was extended by 
Krishnamoorthy and Thomas (2004). Hoffman and Kringle (2005) proposed a 
methodology for constructing two-sided tolerance intervals for general random-effects 
models in both balanced and unbalanced cases. A procedure for constructing a two-sided 
tolerance limits without the normality assumption for both balanced and unbalanced 
ANOVA models by using a nested bootstrap method was proposed by Shoung et al. 
(2005). However, all the aforementioned analytical methods are based on a cross-
sectional approach and therefore do not utilize the longitudinal structure of the data 
(which can lead to more accurate tolerance intervals) or used distribution-free methods 
which have limitations in small samples since they are based on order statistics. The last 
two aforementioned methodologies [Hoffman and Kringle (2005), and Shoung et al. 
(2005)] use the β-content tolerance intervals procedure which are mainly intended for 
drugs where the risk of adverse side effects rapidly increases with an overdose, i.e. even a 
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minor overdose may result in death (Petzold, 2001). Jonsson (2003) proposed a new 
methodology that not only took into account the longitudinal structure of the data but also 
used the β-expectation tolerance intervals procedure which are intended for drugs where 
the expected outcome of an overdose may not cause death (Petzold, 2001). However, 
Jonsson’s approach to tolerance intervals treats the slopes as a fixed effect and needs to 
be enhanced since the random-effects slopes are of extreme importance to the 
pharmaceutical industry.  
In summary, the main difference between the fixed-effects models and the 
random-effects models is that the random-effects model incorporates the fact that batches 
are considered a random sample drawn from the population of all production batches, 
including future ones if the process does not change. Hence, the intercepts and slopes 
used to characterize the degradation of a drug product should be considered as random 
variables.  
 
1.3. Objective 
The aim of the present work is to describe and illustrate tolerance interval 
methods based on random-effects and fixed-effects models. We will also describe 
methods for confidence intervals and prediction intervals based on fixed-effects models. 
Methods for tolerance intervals in the random-effects setting will be based on those 
described by Jonsson (2003) while models for tolerance intervals in the fixed-effects 
setting will be based on those described by Wilks (1941) and Graybill (1976). In Chapter 
2, we will introduce the fixed-effects model, the random-effects model, and the interval 
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estimates. In Chapter 3, we will demonstrate the results from the methodology using an 
analysis dataset. In Chapter 4, we will draw the conclusion from the analysis and make 
suggestions for future research.  
 
8 
2 Methodology  
 
2.1. Introduction 
In this chapter, we introduce the fixed-effects model (Section 2.2) and the random-effects 
model (Section 2.3). Methods for describing confidence intervals, prediction intervals, 
and tolerance intervals are described in Sections 2.4, 2.5, and 2.6 respectively.  
 
2.2. The Normal Fixed-Effects Model Definition 
The fixed-effects model is of the form 
 ,= +y Xα ε  (2.1) 
where 
 y is an 1n×  vector of observed response values, 
 X is an ( )n p n p× > observed design matrix corresponding to the fixed-effects, 
 a is a 1p× vector of fixed-effects parameters, and 
 ε is an 1n× unobservable vector of residuals. 
The residuals , = 1, ,i i nε … are assumed to be independent and identically 
distributed ( ), 2N 0 σ . Thus, the variance of y, ( )var  =y V is given by 
= = I = var( ) var( ) 2V Xα + ε ε σ , where I is an n n×  identity matrix. 
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2.3. The Normal Random-Effects Model Definition 
The random-effects model introduced by Laird and Ware (1982) extends the fixed-effects 
model in equation (2.1) such that 
      ,= + +y Xα Zβ ε  (2.2) 
where 
 y , X , a , andε are as defined in the fixed effects model, 
 Z is an n q× observed design matrix for the random-effects, and  
 β is the 1q × vector of random-effects/coefficients parameters. 
The covariance of y, var(y) = V given by V = var(Xα + Zβ + ε). This model assumes that 
the random-effects and the residuals are independent so that     
    V = var(Xα) + var(Zβ) + var(ε). 
Since α describes the fixed-effects parameters, var(Xα) = 0. Hence, 
V = Zvar(β)Z’ + var(ε). 
Under the assumption that the random-effects follow normal distributions and letting 
 var(β) = G we obtain 
 ,V = ZGZ’+ Σ  (2.3) 
whereβ ~N(0,G) and ε ~N(0,Σ). 
 
 
    10
2.4. Confidence Interval Definition 
For a fixed-effects simple linear regression model, consider estimating the mean response 
of a population given particular values of the predictor x. A two-sided 100(1 – α)% 
confidence interval for the mean response
0Y x
µ is given by 
2
0
0 1 22
1
( )1
ˆ ,
( )
n
i
i
x xy t s
n
x x
α
−
=
−± +
−∑
 (2.4) 
where 0yˆ  
 represents the estimate of the mean response at 0x x= , 
 n is the population size, and 
 
1
2
t α
−
is the 1 2
α
− percentile of the central t-distribution with n-2 degrees of freedom. 
 
2.5. Prediction Interval Definition 
For the fixed-effects simple linear regression model, consider predicting the response of a 
single future observation given particular values of the predictor x. A two-sided 100(1 – 
α)% prediction interval for a single response value 0Y is given by  
 
2
0
0 1 22
1
( )1
ˆ 1 ,
( )
n
i
i
x xy t s
n
x x
α
−
=
−± + +
−∑
 (2.5) 
where 
 0yˆ represents the estimate of the mean response at 0x x= , 
 n is the population size, and 
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1
2
t α
−
is the 1 2
α
− percentile of the central t-distribution with n-2 degrees of 
freedom. 
 Confidence intervals reflect the uncertainty in estimating the mean response 
which is a function of the parameter estimates. Prediction intervals reflect the uncertainty 
from the parameter estimates as well as the uncertainty of a future observation. This is 
why prediction intervals are wider than confidence intervals. Comparing the two 
formulae in equation (2.4) and equation (2.5), the prediction intervals include an extra 
“1” in the square root which reflects the additional uncertainty. 
 
2.6. Tolerance Interval 
2.6.1 Introduction 
In this section, we first define the tolerance interval introduced by Wilks (1941) as it 
applies to cross-sectional data under the fixed-effects model. We then define the β-
content tolerance interval described by Graybill (1976) under the fixed-effects model as it 
applies to longitudinal data. We finally describe the methods used for estimation of the β-
expectation tolerance interval as it applies to longitudinal data in the normal random-
effects setting as it was introduced by Jonsson (2003).  
 Consider estimating a number pγ such that a ( )1 p− proportion of the responses in 
the population under study is below it; or two numbers 1 / 2, / 2p pγ γ− such that 
a ( )1 p− proportion of the responses in the population is between the two numbers. Let 
the assay result (e.g., percent of label claim) be represented by a continuous random 
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variable Y with cumulative distribution function F, and let 1w and 2w be defined by the 
relation 1 2 1 2( ) ( ) ( )YP w Y w F w F w β< < = − = , where β is a predetermined probability. A 
β-expectation tolerance interval requires that 100β% of the individual responses from the 
batches fall between the estimated limits on the average; that is, the expectation over 1wˆ  
and 2wˆ , ( )1 2ˆ ˆ( )YE P w Y w< < , equals β exactly or at least approximately (Jonsson, 2003).  
Though β-expectation tolerance intervals can be constructed with or without 
distributional assumptions, distribution-free tolerance limits have limitations in small 
samples, as they are based on order statistics (Y(r), Y(n-r+1)) with r < (n+1)/2.  
 
2.6.2 Wilks’ Method for Tolerance Interval 
Let the independent and identically distributed random variables 1, , nY Y… from a 
normal distribution N(µ, σ2) represent a cross-sectional sample at some time. If Y is a new 
observation from N(µ, σ2) and if Y and S2 are the unbiased estimators of µ and σ2, 
respectively, then Y Y
S
− is distributed as ( 1)
11 nT
n
−
+ , where ( 1)nT − denotes a Student T-
variable with n-1 degrees of freedom. Hence, the β-expectation tolerance bounds at each 
time point introduced by Wilks (1941) are of the form  
 ,CY K S±  (2.6) 
where 
 1 ( 1)
2
1
 1C
n
K t
n
β+
−
= +  (2.7) 
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 and 1 ( 1)
2
n
t β+
−
is the 100( 1 2β+ )-percentile in the distribution of ( 1)nT − . 
 
 
 
2.6.3 Graybill’s Method for Tolerance Interval 
For a fixed-effects simple linear regression model, consider finding a range of values 
expected to contain a certain percentage of observations from a population with some 
specified level of confidence. The thQ  tolerance limits at the point 0x  and with 
confidence coefficient 1 α−  is of the form  
 0 1 0ˆ ˆ ˆQx gα α σ+ ±  (2.8) 
where Qg  is given by 
    
: ;( )
2
2 0
2
,
( )1
,( )
Q n p
i
g At
x xA
n x x
α θ−=
−
= +
−∑
 
: ;( )n ptα θ−  is the upper α probability point of the noncentral t distribution with n – p degrees 
of freedom and noncentrality parameter Q
N
A
θ = . 
    
2.6.4 Jonsson’s Method for Tolerance Interval 
2.6.4.1 Introduction 
 A considerable improvement of Wilks’ method for tolerance intervals can be 
achieved by utilizing the longitudinal structure of the data so that all the n subjects are 
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used at each time point. Using the pharmaceutical stability framework, a mixed-effects 
model, the variance components regression model, used by Jonsson (2003) is defined as 
 j i ijt ,  1, , ,  1, ,  ,  ijY i T j nµ δ ε= + + = … = …  (2.9) 
where 
ijY is the assay result (percent label claim) for the jth batch at the ith time point, 
jµ is a random-effect that reflects factors that are specific to the jth batch, 
δ is a fixed-effect which expresses the change over time common to all batches,  
it represent the time points at which the response is defined, and 
ijε is a random residual that summarizes the effects of all factors that have not been 
included in the model. 
 The β-expectation tolerance bounds at time t for the random-effects model are 
given by  
 
ˆ ˆ
ˆ ,t LK Vµ ±  (2.10) 
where ˆtµ and ˆV are estimators of the mean and the square root of the variance of ijY , 
respectively, and are based on all nT observations. The quantity ˆ LK depends on the time t 
and is estimated from the data whereas KC in equation (2.7) is a constant across 
time. ˆ LK is determined so that the β-expectation property holds.  
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2.6.4.2 Estimation  
 The problem with constructing tolerance bounds using equation (2.9) are two 
fold: to find a good estimator of V and to determine the value of ˆ LK , which depends upon 
the distribution of 
ˆ
ˆ
ij tY
V
µ−
. One approach is to use a Taylor series approximation so that 
the tolerance bounds have at least approximately the β-expectation property.    
We assume that the jµ , j = 1, …, n, are identically distributed N(α, σU2) and the 
εij, j = 1, …, n, i = 1, …, T, are identically distributed N(0, σε2). We also assume that 
the jµ and the εij are independent of each other. Thus the Yij are N(α + δti, σU2 + σε2). The 
tolerance interval is estimated as 1 2 ˆ ˆ ˆ ˆˆ ˆ ˆ ˆ( , ) ( , )i L i Lw w K V K Vµ µ= − + , where ˆˆˆi itµ α δ= + is an 
estimator of i itµ α δ= + and ˆV is some unbiased estimator of 2 2U=V εσ σ+ .    
Based on data from the jth batch, let ˆ jα and ˆjδ be the ordinary least squares estimators of α 
and δ . The best unbiased estimators of α and δ, αˆ and ˆδ , are given by 
1
ˆ
ˆ
n
j
j n
α
α
=
=∑  and 
1
ˆ
ˆ
n
j
j n
δδ
=
=∑ , respectively. In addition, we define the corrected sum of squares as 
2
1
( )
T
tt i
i
W t t
=
= −∑ , where
1
T
i
i
t
t
T
=
=∑  is the mean time. Then, 
2 2 2 2
U ( )ˆ
ˆ , .
i
i i
tt
t t
t N t
n nW
ε εσ σ σα δ α δ + −+ + + 
 
∼  
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 Let ' ˆˆ
r i Lw K Vµ= ± , (r = 1, 2) be provisory estimators such that LK is an arbitrary 
constant. Since V( 'ˆ
r
w ) = V( 'wˆ ), using a Taylor series approximation we obtain 
 ( ) ( )'' ' (2) (2)2 1 2 1 2 1ˆV( )ˆ ˆ( ) ( ) ( ) ( ) ( ( ) ( ) .2
wE F w F w F w F w F w F w− ≈ − + −  (2.11) 
If we let F be the cdf of a normally distributed random variable with variance V2 and Φ  
be the cdf of a corresponding standardized variable, we obtain the following three 
relations: 
2 1( ) ( ) 2 ( ) 1,LF w F w K− = Φ −  
2
L(2) (2)
2 1 2
-2K exp{ }
2( ) ( ) ,
2
LK
F w F w and
V pi
−
− =  
'
2
2 2 2 2
2U
ˆˆ ˆ
ˆˆ( ) ( ) ( )
ˆ ˆ
ˆ( ) ( )
( )
ˆ( ).
i L i L
i L
i
L
tt
V w V K V V t K V
V t K V V
t t K V V
n nW
ε ε
µ α δ
α δ
σ σ σ
= ± = + ±
= + +
+ −
= + +
 
Thus,  
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( ) 2 2 2 2 2 2' ' U2 1 L2 2 2
2 2 2 2
L2 2
2 2 2 2 L
2U
ˆ( ) ( )1
ˆ ˆ( ) ( ) 2 ( ) 1 K exp{ }
22
ˆ( ) ( )1 12 ( ) 1 K exp{ }
22
-2K( )1
ˆ2 ( ) 1 ( )
2
i L L
L
tt
i L L
L
tt
i
L L
tt
t t K V V KE F w F w K
nV nV W V
t t K V V KK
n V nW V
t tK K V V
n nW
ε ε
ε
ε ε
σ σ σ
pi
σ
pi
σ σ σ
 + −
− = Φ − − + + − 
 
 
−
= Φ − − + + − 
 
 + −
≈ Φ − + + + 
 
2
2
2 2 2 2 2 2
U
L2 2 2
2 2 2
2
L2 2
exp{ }
2
2
ˆ( ) ( )12 ( ) 1 K exp
22
ˆ( )1 1 ( )2 ( ) 1 K exp .
22
L
i L L
L
tt
i L
L L
tt
K
V
t t K V V KK
nV nV W V
t t KV VK K
n V nW V
ε ε
ε
pi
σ σ σ
pi
σ
pi
 
− 
 
 
  
   + −
= Φ − − + + −  
  
   −
= Φ − − + + −  
  
 (2.12) 
 
2.6.4.2.1. Estimation of ˆV  
We define the following sums of squares: 
 
2
1 1
( ) ,
n T
YY ij j
j i
W Y Y
= =
= −∑∑  (2.13) 
 
1 1
( )( ), and
n T
tY i ij j
j i
W t t Y Y
= =
= − −∑∑  (2.14) 
 
2
1
( ) .
n
j
j
S Y Y
=
= −∑  (2.15) 
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1
n
j
j
Y
Y
n
=
=∑ , then, 
2 2
2 1
U( ) , and1 1
nS
n T n
εσ χσ −+
− −
∼ .  
 
2
2 2
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ˆ .( 1) 1 ( 1) 1
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ε
ε
δ σ
σ χ
− −
−
=
− − − −
∼  (2.16) 
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Since
1
S
n −
and 2ˆεσ are independent of each other and ofαˆ and ˆδ , an unbiased estimator 
of 2 2 2UV εσ σ= + is given by 
 
2 2 2 2 1
ˆ
ˆ ˆ ˆ (1 ).
1U
SV
n Tε ε
σ σ σ= + = + −
−
 (2.17) 
Jonsson (2003, Table 1) shows that 2ˆV is in fact a biased estimator of V and therefore 
needs to be corrected. Using a Taylor series expansion, the expectation of V is  
 
2 2
2 2
2 3/2 2 2
ˆ ˆ( ) ( )
ˆ ˆ( ) ( ) [1 ].
8( ) 8( )
V V V VE V E V V V
V V
= ≈ − = −  (2.18) 
This leads to the following adjusted estimator of V  

1
2
2
2 2
ˆ( )
ˆ 1
8( )
V VV
V
−
 
 
−
  
. 
It follows from equations (2.16) and (2.17) that the variance of 2ˆV , 2ˆ( )V V , is of the form 
2 2
2
2 2
2
2 2 4 2
1
ˆ
ˆ( ) (1 )
1
1(1 )
( )
1 ( 1) 1
1( ) (1 )
2[ ].
1 ( 1) 1
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n n T
T T
n n T
ε
ε
ε
ε
ε
σ
σ
σ σ
σ
σ σ
 
= + − 
− 
+ −
= +
− − −
+ −
= +
− − −
 
 This implies that  
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2 2
2 2 2 2 2
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where  
 
2
2 2
1(1 )
.( )U
TR
ε
ε
σ
σ σ
−
=
+
 (2.19) 
Hence an estimator of 2 2UV εσ σ= + is given by 
 
( )
( )
12
2
2 2
ˆ1 ˆ1
ˆ
ˆ ˆ 1 ,
4 1 1 1U
R RV
n n Tε
σ σ
−
  
−  
= + − +  
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 (2.20) 
where  
 
2
2 2
1
ˆ (1 ) ( 1) 3
ˆ
.
ˆ ˆ ( 1) 1U
n TTR
n T
ε
ε
σ
σ σ
−  − −
= ⋅ + − − 
 (2.21) 
 This correction factor involving the estimator ˆR helps reduce the bias in small 
samples since the ratio of the estimated variance components has an F-distribution. 
Jonsson (2003) found through simulation studies that the uncorrected estimator of V has a 
negative bias that decreases in absolute value with increasing values of n, and to a lesser 
extent with increasing values of T. 
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2.6.4.2.2. Estimation of ˆ LK  
Using equation (2.12) and equating it to a predetermined value of β, we may get a 
relationship between R and KL.  
 
( )' '2 1
2 22 2 2
L
ˆ ˆ( ) ( ) 2 ( ) 1
1 1 ( ) (1 )1 +K exp1 2 1 ( 1) 1 22 1
L
L L
tt
E F w F w K
K KR t t R R
n W n n T
T
pi
β
− = Φ − −
  
     − −
+ + + + −      
− − −     
−
   
=
 (2.22) 
where R is given by (2.19).  
We then use this relationship to find an estimated value of KL from an observed value of 
R. We write a quadratic equation in R by equating (2.12) to the predetermined value β 
since it is difficult to write KL as an explicit function of R. This quadratic equation has 
one root of interest. 
Let 
 
2( )
, and1(1 )
i
tt
t tC
n W
T
−
=
−
 (2.23) 
 22
2 (2 ( ) 1 )2 1[ ],
exp{ }
2
L
LL
L
KA
KK nK
pi βΦ − −
= −
−
 (2.24) 
where C is a component that is determined by spacing of the time points at which the 
measurements are made. For a given n and T, C=0 at t t= and reaches the maximum at 
the end points of the range of t. (See Jonsson, 2003 for an example). We could note, 
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however, that the maximum at the end points decreases with increasing T (Jonsson, 
2003). Equation (2.22) becomes 
 
1
2 2 2
2 2
( 1) ( 1)( ( 1) 1)[1 ] [( ( 1) 1) [1 ] ( 2)( ( 1) 1)(1 ( 1) )]
.
2
L L
n C n C
n T n T nT n T n A
K KR
nT
− −
− − − − − − − − − − − − −
=
−
 (2.25) 
 
There exists a one-to-one relationship between R∈(0,1) and KL∈  
LK
I such that R 
decreases with increasing KL. The quantity ˆ LK denotes the value of KL corresponding to 
an estimated value of R given in (2.21). Jonsson (2003) states that KL becomes 
empirically almost linearly dependent on 
 
2 2(1 )
1 ( 1) 1
R RZ
n n T
−
= +
− − −
 (2.26) 
provided the predetermined value (β) is 0.90 or 0.95. For larger values of β, especially for 
small n, we fit KL to polynomial functions of Z. The estimation of KL is done using a 
computer program which is found in the Appendix section. 
 
2.6.4.3 β-Expectation Tolerance Interval 
The estimated 95%-expectation tolerance interval in the population of random 
batches at time t based on longitudinal data is of the form ˆ ˆˆ ˆ ˆ ˆˆ ˆ( , )L Lt K V t K Vα δ α δ+ − + + .  
The values of ˆV and ˆ LK are derived from equations (2.20) and (2.25) respectively. 
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3 Applications 
 
In this chapter, the methodology for estimation proposed in Chapter 2 is studied using an 
example dataset. We demonstrate the results using a random-effects model with data 
from a pharmaceutical stability data simulation which was performed by Obenchain 
(1990).  
    Table 1: Data Structure 
Observations Batch Month Y  
1 1 0 102.783 
2 1 1 99.350 
3 1 3 98.625 
4 1 6 101.525 
5 1 9 96.750 
6 1 12 97.350 
7 2 0 102.550 
8 2 1 99.650 
9 2 3 104.100 
10 2 6 101.275 
11 2 9 95.850 
12 2 12 93.167 
13 3 0 104.583 
14 3 1 101.200 
15 3 3 101.600 
16 3 6 100.850 
17 3 9 100.925 
18 3 12 97.467 
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The data set represents measurements from three batches. Six replicate assay results, 
expressed in percent label claim, were measured in months at different storage times, 
specifically at times 0, 1, 3, 6, 9, and 12 months. Hence, the six time points (T=6) were 
considered at t = 0, 1, 3, 6, 9, and 12. For all three batches, two replicate response values 
were missing at times 1, 3, 6, and 9 months. For all three batches, the process begins with 
a computation of the mean of the replicate assay results across the six replicates. The 
dataset follows a structure as seen in Table 1. 
 
3.1. Presenting Results from the Analysis 
Recall that the confidence limits are of the form
2
0
0 1 22
1
( )1
ˆ
( )
n
i
i
x xy t s
n
x x
α
−
=
−± +
−∑
. We compute 
the 95% confidence interval for the mean of the assay results across the three batches at 
time 0 month under the fixed-effects model to obtain the values 102.55 and 0.7694 
for 0yˆ and ( )0ˆse y , respectively. Note that ( )
2
0
0
2
1
( )1
ˆ
( )
n
i
i
x x
se y s
n
x x
=
−
= +
−∑
. This yields a 
confidence interval of (100.92, 104.18). The 95% confidence intervals for the mean 
response at the remaining time points are displayed in Table 2. Confidence intervals for 
the random-effects model are not discussed in this thesis. 
A 95% prediction interval that will contain a single future observation from a 
population of size n is of the form
2
0
0 1 22
1
( )1
ˆ 1
( )
n
i
i
x xy t s
n
x x
α
−
=
−± + +
−∑
. For example if we were 
    24
interested in predicting the response from a single future observation at month 0, then a 
95% prediction interval is (97.83, 107.26). These intervals are computed for the fixed-
effects model and the corresponding prediction intervals for months 1 – 12 are 
summarized in Table 2. Prediction intervals for the random-effects model are not 
discussed in this thesis. 
Using the cross-sectional structure of the data under the fixed-effects model, the 
95%-expectation tolerance of the responses for any batch in the population is of the 
form CY K S± , where 0.975(2)
1 11 4.303 1 4.303 1.1547 4.970
3 3C
K t= + = + = × =  and 
1 ( 1)
2
n
t β+
−
is the 100( 1 2β+ )-percentile in the distribution of ( 1)nT − . At month 0, this interval is 
(97.78, 108.83). The tolerance intervals for the remaining time points can be found in 
Table 3. 
Recall that under the fixed-effects model, the 95% tolerance interval that contains 
at least 95% of the population described by a normal distribution is of the form 
0 1 0 0 1 0ˆ ˆ ˆ ˆˆ ˆ( , )Q Qx g x gα α σ α α σ+ − + +  (Graybill, 1976). Using a longitudinal data structure 
approach, the 95% tolerance interval that contains at least 95% of the population 
described by a normal distribution under the fixed-effects model at month 0 is (95.61, 
109.49). The tolerance intervals for the remaining time point are given in Table 3. 
However, using the longitudinal structure of the data under the random-effects 
model, the 95%-expectation tolerance interval of the responses for any batch in the 
population is of the form ˆ ˆˆ ,t LK Vµ ± where the values of ˆ LK are given in Table 3. Using the 
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SAS Software, a regression analysis on the pairs ( , )i ijt Y was done using a random-
effects model definition in PROC MIXED. The computation yielded the following 
values: 
102.78, 3.5, 110.83,
ˆ
ˆ1.90, 102.55, 0.49724
ˆ ˆ0.25771, 4.16493
tt
U
Y t W
B
ε
α δ
σ σ
= = =
= = = −
= =
 
At this point ˆ LK needs to be determined. Unfortunately, the expression in equation (2.25) 
does not readily yield values for ˆ LK given R, n, T, C, and A. Instead, the expression is 
solved for R by iterating through various values of ˆ LK  at different time points. Fitting KL 
to polynomial functions of Z using equation (2.26) gives ˆ ˆ0.67266 2.14916R and V= =  
for equations (2.21) and (2.20) respectively. For example, let’s assume that a value of ˆ LK  
corresponding to ˆ 0.6727R =  is desired to construct a 95% tolerance interval at t = 0 
months. Let’s further assume that n = 3, T = 6, t and ttW  are given as aforementioned. 
The computer program (see Appendix) gives a list of values of ˆ ˆ( , )LK R from which two 
pairs are of our interest: (2.3793, 0.6724) and (2.3821, 0.6673). We conclude from these 
two pairs that ˆ LK is found in the interval (2.3793, 2.3821) since ˆR belongs to the interval 
(0.6673, 0.6724). Through a series of iteration of ˆ LK from 2.3793 to 2.3821 gives 
ˆ ˆ( , )LK R = (2.3809, 0.6720). Therefore, the solution is ˆ 2.3809LK ≈ . The estimated 95%-
expectation tolerance interval for the response Y at month 0 under the random-effects 
model is (97.43, 107.66). The variation in the intervals from one time point to another is 
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due to the change in ˆ LK . The tolerance intervals are computed and given in Table 3. 
Figure 1 shows a graph of the Jonsson’s, Wilks’, and Graybill’s tolerance intervals. 
 
Table 2: 95% Confidence & Prediction Intervals 
 
  Wilks' 
 S.D. S.E. Predicted 95% CI 95% P.I. 
Month Y  ˆY  S  ( )0ˆse y  Fixed Fixed 
0 103.31 102.55 1.1126 0.7694 (100.92, 104.18) (97.83, 107.26) 
1 100.07 102.05 0.9930 0.6853 (100.60, 103.50) (97.39, 106.71) 
3 101.44 101.06 2.7409 0.5510 (99.89, 102.22) (96.48, 105.63) 
6 101.22 99.56 0.3413 0.5012 (98.50, 100.63) (95.01, 104.01) 
9 97.84 98.07 2.7079 0.6593 (96.67, 99.47) (93.43, 102.71) 
12 96.00 96.58 2.4495 0.9242 (94.62, 98.54) (91.74, 101.42) 
 
 
 
Table 3: 95% Tolerance Intervals 
 95% T.I.  
Month 
Random 
(Jonsson) 
Fixed 
(Graybill) 
Fixed 
(Wilks) 
ˆ
LK  
0 (97.43, 107.66) (95.61, 109.49) (97.78, 108.83) 2.3809 
1 (96.94, 107.16) (95.23, 108.87) (95.13, 105.00) 2.3768 
3 (95.95, 106.16) (94.43, 107.69) (87.82, 115.06) 2.3768 
6 (94.41, 104.71) (92.99, 106.13) (99.52, 102.91) 2.3969 
9 (92.83, 103.31) (91.29, 104.85) (84.39, 111.30) 2.4381 
12 (91.22, 101.94) (89.39, 103.77) (83.82, 108.17)  2.465 
27 
 
Figure 1: Tolerance Intervals 
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3.2. Discussion and Summary of the Analysis 
Under the fixed-effects model, the 95% confidence intervals for the mean of the assay 
results across the three batches are narrower than the 95% prediction intervals. This is 
mainly justified from the fact that the formula for the 95% prediction intervals include an 
extra “1” which reflects the additional uncertainty that emanate from a future 
observation. Tolerance intervals obtained under either the fixed-effects or random-effects 
model using the longitudinal structure of the data are more appropriate than tolerance 
intervals computed under the fixed-effects model using the data from a cross-section at 
each time point. This is an evidence since the former does not use the entire data. Using 
the longitudinal data structure, the tolerance intervals obtained from Jonsson’s method 
under the random-effects model are narrower than the tolerance intervals obtained from 
Graybill’s method under the fixed-effects model. The difference between the two types of 
tolerance intervals is due to the fact that Graybill’s method for tolerance interval does not 
incorporate a random effect into the model. We should also notice that there are some 
fundamental differences between Jonsson’s method, Graybill’s method, and Wilks’ 
method for tolerance intervals. Jonsson’s method uses the concept of β-expectation 
tolerance interval under the random-effects model for a longitudinal data structure; the 
covariance structure is compound symmetry. Graybill’s method uses the concept of β-
content tolerance interval under the fixed-effects model for a longitudinal data structure; 
the covariance structure does assume independence. Wilks’ method uses the concept of 
β-expectation tolerance interval under the fixed-effects model for a cross-sectional data 
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structure; no covariance structure is assumed under Wilks’ method. The tolerance 
intervals for Jonsson’s, Wilks’, and Graybill’s methods are shown in Figure 1. 
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4 Conclusions and Future Research 
In this thesis, we described three types of intervals estimates using longitudinal 
structured data. We first began by introducing the fixed-effects model which treated our 
population parameter of interest as being fixed with respect to time. We built on the fact 
that the population parameter of interest was in fact a random-effects parameter as was 
indicated by most recent methodology. In fact, a major concern in the pharmaceutical 
industry is that most methodology treats the batches as a fixed effects and therefore 
ignores the between-batch variability. Inference made based on fixed-effects models are 
not applicable to future or unobserved batches. Therefore, the use of statistical methods 
based on a random-effects model (treating intercepts and/or slopes as a random-effects) is 
more appropriate for establishing the expiry period applicable to future production 
batches.  
We illustrated the confidence intervals for the predicted mean, which are 
commonly used to establish the expiry period of a drug product. We then described the 
prediction intervals for a predicted new assay value and the tolerance intervals for a 
proportion of the population which are sometimes used in risk assessment. However, it is 
more appropriate to use tolerance intervals in order to assess the risk of product failure at 
expiry since they provide an interval estimate for the proportion of assay values in the 
population failing at the expiry period.  
We focused our attention to the β-expectation tolerance interval, which requires 
that 100β% of the individual responses from the batches fall between the estimated limits 
on the average. We chose not to use the other type of tolerance interval, the β-content 
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tolerance interval, because they are mainly intended for drugs where the risk of adverse 
effects rapidly increases with an overdose such that even a minor overdose may result in 
death (Petzold, 2001). Our choice of tolerance interval, the β-expectation tolerance 
interval, is intended for drugs where the expected outcome of an overdose may only 
cause discomfort (Petzold, 2001). Since our main interest is on over-the-counter 
medications, the use of this type of tolerance interval is more appropriate. Furthermore, 
β-content tolerance intervals appear to be too wide for samples when the within-batch or 
the between-batch variability is large [Jonsson (2003), Hoffman and Kringle (2005)].  
We compared tolerance intervals based on cross-sectional data to tolerance 
intervals based on longitudinal data. This led us to the conclusion that it is more 
appropriate to use tolerance intervals derived from longitudinal than those obtained from 
cross-sectional data since the latter do not use the entire data. This was shown in greater 
detail by Jonsson (2003).  
We finally used the longitudinal data structure to compare tolerance intervals obtained 
using Jonsson’s approach under the random-effects model to tolerance intervals using 
Graybill’s method under the fixed-effects model. We found that the tolerance intervals 
obtained from Jonsson’s method are narrower than the tolerance intervals obtained from 
Graybill’s method. This weakness in Graybill’s methodology is due to the fact that it 
does not incorporate a random effect into the model.  
Thus, our findings have led us to a few limitations with the data used for the 
purpose of the analysis and the methods used for the computation of the random-effects 
tolerance intervals. In fact, most pharmaceutical stability data are limited when it comes 
    32
to the number of batches used. Even though the FDA recommends that at least three 
batches be used in the analysis of stability data, the minimum number of three batches 
seems too small for the computation of statistical intervals. The dataset used in our 
analysis which was performed by Obenchain (1990) falls in the same category. Due to 
the small number of batches, the intervals computed are wide because of the large within 
batch variation ( ˆ 4.16493εσ = ).  
Longitudinal-based methods for computing statistical intervals cannot be used 
without distributional assumptions. However, distribution-free methods are not 
appropriate for small sample sizes.  
The β-expectation tolerance interval presented by Jonsson (2003) is mainly 
intended for small samples where there is a large within or between subjects variation. 
This interval was proven to be superior to Wilks’ (1941) and Graybill’s approaches as the 
lengths of the intervals are smaller on the average, while the β-expectation property is 
simultaneously maintained. This is especially the case when the within subjects variation 
is larger than the between subjects variation. 
 However, the methodology proposed by Jonsson (2003) needs further 
improvement. Researchers need to allow for addition of the random slopes in the model 
since the current approach only allows for random intercepts. This new methodology 
should also account for the case of unbalanced data. A method could be developed to 
incorporate the enhanced Jonsson’s approach to tolerance intervals in the SAS “MIXED” 
procedure.  
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6 Appendices 
 
6.1. SAS Code 
/**********************************************************************
**************** 
***********************************************************************
**************** 
Kakotan Sanogo 
    Under the Guidance of Drs. Jessica M. Ketchum, 
Charles W. Kish, 
    and Ramakrishnan Viswanathan 
    Department of Biostatistics, Viginia Commonwealth 
University 
    Division of Statistics, Wyeth Consumer Healthcare  
Modified on: 11-Dec-2008 
Dataset: Obenchain (1990) 
References: Analysis of Messy Data, Miliken & Johnson, 2002 
   The Theory and Application of the Linear Model, 
Graybill, 1976 
   A Longitudinal Approach for Constructing beta-
Expectation 
   Tolerance Intervals, Jonsson, 2003 
   Determination of Sample Sizes for Setting Tolerance 
Limits, Wilks, 1941 
***********************************************************************
*************** 
***********************************************************************
**************/ 
 
 
data rc;  
   input batch month r1-r6;  
   array r{6};  
   monthc = month;  
   drop i r1-r6;  
   do i = 1 to 6;  
      y = r{i};  
      if (y ^= .) then output;  
   end;  
    datalines;  
1   0  101.2 103.3 103.3 102.1 104.4 102.4  
1   1   98.8  99.4  99.7  99.5    .     .  
1   3   98.4  99.0  97.3  99.8    .     .  
1   6  101.5 100.2 101.7 102.7    .     .  
1   9   96.3  97.2  97.2  96.3    .     .  
1  12   97.3  97.9  96.8  97.7  97.7  96.7  
2   0  102.6 102.7 102.4 102.1 102.9 102.6  
2   1   99.1  99.0  99.9 100.6    .     .  
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2   3  105.7 103.3 103.4 104.0    .     .  
2   6  101.3 101.5 100.9 101.4    .     .  
2   9   94.1  96.5  97.2 95.6     .     .  
2  12   93.1  92.8  95.4 92.5   92.2  93.0  
3   0  105.1 103.9 106.1 104.1 103.7 104.6  
3   1  102.2 102.0 100.8  99.8    .     .  
3   3  101.2 101.8 100.8 102.6    .     .  
3   6  101.1 102.0 100.1 100.2    .     .  
3   9  100.9  99.5 102.5 100.8    .     .  
3  12   97.8  98.3  96.9  98.4  96.9  96.5  
;  
proc sort; by batch month;  
proc means; by batch month; var y; output out = ymeans mean = y;  
proc print data = ymeans; 
run; 
data test; 
 set ymeans(keep=batch month y); 
 proc print; 
run; 
 
***********************************************************************
******** 
***********************************************************************
******** 
COMPUTATION OF CONFIDENCE INTERVALS: FIXED-EFFECTS MODEL 
***********************************************************************
******** 
***********************************************************************
********; 
****** Method ONE; 
proc mixed data = test; 
class  batch; 
 model y = month /solution outp = out1 outpm = out2 cl; 
 title '95% Confidence Intervals for the Fixed-Effects Model'; 
run; 
proc print data = out2; 
run; 
 
****** Method TWO; 
proc mixed data = test; 
class  batch; 
 model y = month /solution outp = out1 outpm = out2 cl; 
 title '95% Confidence Intervals for the Fixed-Effects Model'; 
 estimate "time0" intercept 1 month 0/ cl df=16; 
 estimate "time1" intercept 1 month 1/ cl df=16; 
 estimate "time3" intercept 1 month 3/ cl df=16; 
 estimate "time6" intercept 1 month 6/ cl df=16; 
 estimate "time9" intercept 1 month 9/ cl df=16;  
 estimate "time12" intercept 1 month 12/ cl df=16; 
run; 
 
**** Method THREE; 
proc glm data=test ; 
 model y=month / SS3 clm  ;   *clm Prints 95% confidence  
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        intervals for the 
mean of each observation ; 
    title '95% Prediction Intervals for the Fixed-Effects Model'; 
 estimate "time0" intercept 1 month 0 ; 
 estimate "time1" intercept 1 month 1 ; 
 estimate "time3" intercept 1 month 3; 
 estimate "time6" intercept 1 month 6; 
 estimate "time9" intercept 1 month 9;  
 estimate "time12" intercept 1 month 12;   
run; 
 
***********************************************************************
******** 
***********************************************************************
******** 
COMPUTATION OF CONFIDENCE INTERVALS: RANDOM-EFFECTS MODEL 
***********************************************************************
******** 
***********************************************************************
********; 
*****Method ONE; 
proc mixed data = test; 
 class  batch; 
 model y = month / s cl outpm=predm ;     
 random  int month/ sub=batch s g v;  
 title '95% Confidence Intervals for the Randam-Effects Model'; 
run; 
proc print data = predm; 
run; 
 
******Method TWO; 
proc mixed data = test; 
class  batch; 
 model y = month /solution outp = out1 outpm = out2 cl ; 
 random intercept month / sub = batch type = un solution v vcorr; 
 title '95% Confidence Intervals for the Randam-Effects Model'; 
 estimate "time0" intercept 1 month 0/ cl df=12; 
 estimate "time1" intercept 1 month 1/ cl df=12; 
 estimate "time3" intercept 1 month 3/ cl df=12; 
 estimate "time6" intercept 1 month 6/ cl df=12; 
 estimate "time9" intercept 1 month 9/ cl df=12;  
 estimate "time12" intercept 1 month 12/ cl df=12; 
run; 
 
/******************************************************************* 
******************************************************************* 
COMPUTATION OF PREDICTION INTERVALS: FIXED-EFFECTS MODEL 
******************************************************************* 
*******************************************************************/ 
proc glm data=test; 
 model y=month / SS3 cli  ;   *cli Prints 95% prediction  
        intervals for the mean 
of each observation ; 
title '95% Prediction Intervals for the Fixed-Effects Model'; 
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 estimate "time0" intercept 1 month 0 ; 
 estimate "time1" intercept 1 month 1 ; 
 estimate "time3" intercept 1 month 3; 
 estimate "time6" intercept 1 month 6; 
 estimate "time9" intercept 1 month 9;  
 estimate "time12" intercept 1 month 12;   
run; 
 
/******************************************************************* 
******************************************************************* 
COMPUTATION OF PREDICTION INTERVALS: RANDOM-EFFECTS 
******************************************************************* 
*******************************************************************/ 
 
%let _time=Month; 
%let _alpha=0.05; 
 
proc mixed data =test ;  
 
   class batch ;  
   model y = &_time / s cl outpm=predm ;     
       random  int &_time/ sub=batch s g v;  
          ods output solutionf=solutionf;  
    ods output solutionr=solutionr; 
          ods output covparms=covparms;  
          ods output dimensions=dim;  
          ods output tests3=tests3;  
          ods output nobs=nobs;  
          ods output ClassLevels=class;  
run ;  
 
 
 
/* PRINT DATASETS CREATED FROM PROC MIXED */ 
data dim2;                                                                              
        set dim;    
  do i=1 to 18 by 1;  
        if descr='Subjects' then                                                             
           do;                                                                               
              n_subj=value;                                                                  
              df_intercept = n_subj - 1;                                                     
              df_slope = n_subj - 1;     
     call symput('_n_subj', n_subj);   
              output;                                                                        
            end;                                                                        
  keep n_subj df_intercept df_slope; 
 end; 
 %put &_n_subj; 
run; 
  proc print data=dim2;run; 
 
*********************************************************************** 
     CREATE A DATASET WITH NUMBER OBS USED IN ANALSIS AND 
     DEGREES OF FREEDOM FOR MSE 
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*********************************************************************
**; 
   data nobs2; 
      set nobs; 
   do i=1 to 18 by 1;  
      if label="Number of Observations Used" then 
         do; 
           n_tot=n; 
     df_err = n_tot - (2*&_n_subj);  
           output; 
      end; 
      keep n_tot df_err ; 
   end; 
   run; 
proc print data=nobs2;run; 
   
***********************************************************************
* 
      CREATE DATASET OF INTERCEPT ESTIMATES USING PREDM DATASET 
   & MERGE WITH PREDM DATASET 
   
***********************************************************************
; 
   data intercept; 
    set predm; 
    if &_time=0 then  
          do; 
             intercept=pred;    
    output; 
    end; 
       keep  batch &_time intercept; 
   run; 
   proc print data=intercept;run; 
 
   proc sort data=intercept out=intercept; by  batch; 
 proc sort data=predm out=predm; by  batch; 
 
    
 data predm_int; 
     merge predm intercept; 
  by  batch; 
 run; 
proc print data=predm_int;run; 
 
 data predm_int2; 
    set predm_int(rename=(intercept=temp_int)); 
    retain x .; 
       intercept=temp_int; 
       if temp_int ne ' ' then x = intercept; 
       else if temp_int = ' ' then intercept = x; 
       drop x temp_int; 
    run; 
 proc print data=predm_int2;run; 
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***********************************************************************
* 
      CREATE DATASET OF SLOPE ESTIMATES USING PREDM DATASET  
   & MERGE WITH PREDM / INTERCEPT DATASET 
   
***********************************************************************
; 
 data slope; 
    set predm_int2; 
    if &_time ne 0 then 
       do; 
            slope = (pred - intercept) / &_time; 
    output; 
    end; 
       keep  batch &_time slope; 
 run; 
proc print data=slope;run; 
   
 proc sort data=slope; 
       by  batch descending &_time; 
 run; 
 
 proc sort data=predm_int2; 
       by  batch descending &_time; 
 run; 
 
 data predm_int_slope; 
     merge predm_int2 slope; 
  by  batch; 
 run; 
proc print data=predm_int_slope;run; 
 
 data predm_int_slope2; 
    set predm_int_slope(rename=(slope=temp_slope)); 
    retain x .; 
       slope=temp_slope; 
       if temp_slope ne ' ' then x = slope; 
       else if temp_slope = ' ' then slope = x; 
       drop x temp_slope; 
  run; 
  proc print data=predm_int_slope2;run; 
 
   
***********************************************************************
* 
     CREATE A DATASET WITH MSE & MERGE WITH PREDICTED VALUES DATASET 
   
***********************************************************************
;   
 proc print data=covparms; 
 run; 
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    data covparms2; 
      set covparms; 
      retain var_intercept var_slope var_err; 
   do i=1 to 18 by 1; 
    if covparm='Intercept' then var_intercept=estimate; 
       else if covparm="&_time" then var_slope=estimate; 
       else if covparm='Residual' then  
          do; 
            var_err=estimate; 
      output; 
    end; 
    drop covparm estimate; 
   end; 
    run; 
  proc print data=covparms2;run; 
 
 
  
    
***********************************************************************
* 
      COMBINE PREDM/INTERCEPT/SLOPE, COVPARM, & NOBS ESTIMATES 
    
***********************************************************************
; 
  proc sort data=predm_int_slope; 
       by  batch descending &_time; 
 run; 
   
 data reg_est; 
    merge predm_int_slope2 covparms2 dim2 nobs2; 
    *by batch; 
 run; 
   proc print data=reg_est;run; 
 
 *****************************************************************
******* 
      RESTRUCTURE RANDOM EFFECT DEVIATES DATASET 
    
***********************************************************************
; 
 proc sort data=solutionr out= solutionr;by batch ; 
 
proc print data=solutionr; 
run; 
 
 
    data solutionr2; 
    set solutionr; 
       by batch; 
       retain effect_i effect_s .; 
       if effect="Intercept" then effect_i=estimate; 
       else if effect ne "Intercept" then effect_s=estimate; 
       if last.batch then output; 
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    keep batch effect_i effect_s; 
    run; 
 proc print data=solutionr2;run; 
  
    
***********************************************************************
* 
      COMBINE PREDM/INTERCEPT/SLOPE/COVPARM/NOBS WITH RANDOM EFFECT 
DEVIATES ESTIMATES 
    
***********************************************************************
; 
 proc sort data=solutionr2 out= solutionr2;by batch; 
 proc sort data=reg_est out= reg_est;by batch; 
 data reg_est2; 
    merge reg_est solutionr2; 
    by batch; 
 run; 
 proc print data=reg_est2;run; 
  
   
***********************************************************************
* 
    COMPUTE  LOWER PREDITION LIMIT 
   
***********************************************************************
; 
   data reg_est3; 
      set reg_est2; 
 
   *** standard error of the predicted value based on the mixed 
model; 
   *** assumes no covariance between intercept & slope; 
     var_pred_vc=var_intercept + ((&_time**2)*var_slope) + var_err; 
 
   *** degrees of freedom based on satterthwaites approximation; 
        num= ((var_intercept + ((&_time**2)*var_slope) + var_err)**2); 
        denom= ((var_intercept**2)/df_intercept) + 
((((&_time**2)*var_slope)**2) / df_slope) + ((var_err**2) / df_err); 
 
       df_sw = num/denom; 
 
    fcrit=finv(1-&_alpha,2,df_sw); 
    
    * f-distribution check; 
    fcrit_ck=finv(1-&_alpha,2,70); 
    scheffe_pct_pt = sqrt(2*fcrit_ck); 
 
       piw=sqrt(2*fcrit)*sqrt(var_pred_vc); 
 
       *** compute 2-sided upper pred. limits about a future obs.; 
    pred_chk=intercept + (slope*&_time); 
 
       lpl = pred - piw; 
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    upl = pred + piw; 
    int_width=upl-lpl; 
 run; 
   
 proc print data=reg_est3;run; 
 
   
***********************************************************************
* 
    CREATE LISTING OF REGRESSION ESTIMATES AND RELEASE LIMITS (LOWER & 
UPPER) 
   
***********************************************************************
; 
 
    ods select all; 
  
    proc print data=reg_est3 label; 
         var &_time batch  intercept SLOPE pred var_intercept 
var_slope var_err  
             df_intercept df_slope df_err fcrit lpl upl int_width df_sw 
var_pred_vc piw; 
    run; 
 
 
 
 /****************************************************************
*** 
 *****************************************************************
** 
 COMPUTATION OF TOLERANCE INTERVALS: Wilks' Method  
 *****************************************************************
** 
 *****************************************************************
**/ 
  data _stats; 
 input y1 y2 y3@@; 
 datalines; 
102.783  102.55   104.583 
99.35  99.65   101.2   
98.625  104.1   101.6   
101.525  101.275  100.85  
96.75  95.85   100.925 
97.35  93.167   97.467  
 ; 
 run; 
 proc print data=_stats;run; 
  
 data wilks; set _stats; 
  
 *Computing the mean batch;  
 y_bar = mean(y1,y2,y3);  
 
 * Computing the standard deviation; 
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 SD = std(y1,y2,y3); 
  
 K = sqrt(1+1/3)*(4.303);  * where n=3 batches and 4.303 is the 
97.5 percentile  
        in a t distribution 
with 2 degrees of freedom; 
    LTL = y_bar - K*SD; 
    UTL = y_bar + K*SD; 
  run; 
 
  proc print data= wilks; 
    var LTL UTL SD y_bar; 
  run; 
 
/******************************************************************* 
******************************************************************* 
COMPUTATION OF TOLERANCE INTERVALS: Graybill's Method  
******************************************************************* 
*******************************************************************/ 
proc sort data=rc; by batch month;  
proc means; by batch month; var y; output out = ymeans mean = y;  
proc print data = ymeans; 
run; 
data test; 
 set ymeans(keep=batch month y); 
 proc print; 
run; 
proc glm data=test; 
 model y=month / ss3; 
 output out=predcheck predicted=pred h=h; 
run; 
 
proc print data=predcheck; 
run; 
 
data work; 
    length method $9; 
 input method $& alpha p pred mse df h expiry; 
 /* the value of "pred", "mse", "df", and "h" are 
    obtained from the "glm" procedure output and "pred" and "h" 
    vary for different values of "expiry" (from 0 to 12 month). 
    P=0.05 represent the 95% of tolerance point with (1-alpha)=95% 
confidence. 
    The dataset below computes the Graybill's Tolerance Interval  
    at month 0. 
 */ 
 cards; 
 Graybill   .05  .05  102.55  4.3582101  16    0.13584  0 
    ; 
  run; 
 
  proc print data=work; 
  run; 
 data stats;set work; 
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    rootmse=mse**.5; 
 A=h**.5; 
 
    np=probit(1-(p/2)); 
    deltau=-np/A; 
    tcritu=tinv(alpha/2, df, deltau); 
       gpu= - A * tcritu; 
    UTW=gpu * rootmse; 
       UTL = pred + (gpu * rootmse); 
 
       deltal=np/A; 
    tcritl=tinv(1-(alpha/2), df, deltal); 
       gpl= A * tcritl; 
    LTW=gpl * rootmse; 
       LTL = pred - (gpl * rootmse); 
  run; 
 
  proc print data=stats; 
      var LTL UTL; 
  run; 
 
 
/******************************************************************* 
******************************************************************* 
COMPUTATION OF TOLERANCE INTERVALS: Jonsson's Method 
******************************************************************* 
*******************************************************************/ 
 
 /****************************************************************
*** 
 *****************************************************************
** 
 START GLOBAL MACRO 
 *****************************************************************
**  
 *****************************************************************
**/ 
 * First run the global macro and then change the value of _time 
to  
   get the tolerance intervals; 
 %macro bigone(_time, _n, _TotTimes); 
 
 %do _t=0 %to &_time %by 1;   
  data a; 
  set test; 
  i = month; 
  i2 = i*i; 
  Y2 = Y*Y; 
  iY = i*Y; 
  run; 
 proc sort; 
  by batch; 
 run; 
 proc means noprint sum; 
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  var i Y i2 Y2 iY; 
  by batch; 
  output out = sas1 sum = si sY si2 sY2 siY; 
 run; 
 proc print data = sas1; 
 run; 
 data b; 
   set sas1; 
  mt = si/&_TotTimes; mYj = sY/&_TotTimes; mYj2 = 
mYj*mYj; Wttj = si2-si*si/&_TotTimes; 
  WtYj = siY-si*sY/&_TotTimes; WYjYj = sY2-sY*sY/&_TotTimes;
 bj = WtYj/Wttj; aj = mYj-bj*mt; 
 run; 
 proc means noprint sum; 
  var bj aj mYj mYj2 Wttj WYjYj WtYj; 
  output out = sas2 sum = sbj saj smYj smYj2 sWttj sWYjYj 
sWtYj; 
 run; 
 proc print data= sas2; 
 run;  
 
 /* totals */ 
 data c;  
  set sas2; 
  b = sbj/&_n; a = saj/&_n; Wtt = sWttj/&_n; BYY = smYj2-
smYj*smYj/&_n; 
  vare = (sWYjYj-b*sWtYj)/(&_n*(&_TotTimes-1)-1); varu = 
BYY/(&_n-1)-vare/&_TotTimes; 
  R = vare*(1-1/&_TotTimes)*(&_n*(&_TotTimes-1)-
3)/(vare+varu)/(&_n*(&_TotTimes-1)-1); 
  Z = (1-R)*(1-R)/(&_n-1)+R*R/(&_n*(&_TotTimes-1)-1); 
  V = sqrt(vare+varu)/(1-Z/4); 
  call symput('R', R);run; 
 proc print ; 
  var a b Z V R vare varu Wtt BYY; 
 run; 
 
 /****************************************************************
************************** 
 *****************************************************************
************************** 
 THIS MACRO CREATES K_hat for a given TIME POINT 
 *****************************************************************
************************** 
 *****************************************************************
*************************/ 
 
 
 data d; 
 meanT = 2.0; Wtt = 110.83; beta = 0.95; 
 
 const = gamma(1/2)*sqrt(2); 
  do K = 2.0 to 3.0 by 0.0001; 
   C = (&_time - meanT)**2/&_n/(1-1/&_TotTimes)/Wtt; 
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   AA = 2*(const*(exp(K*K/2))*(2*probnorm(K)-1-
beta)/K-1/&_n)/K/K; 
   R_hat = ((&_n*(&_TotTimes-1)-1)*(1-(&_n-1)*C/K/K)-
sqrt((&_n*(&_TotTimes-1)-1)**2*(1-(&_n-1)*C/K/K)**2-(&_n*&_TotTimes-
2)*(&_n*(&_TotTimes-1)-1)*(1-(&_n-1)*AA)))/(&_n*&_TotTimes-2); 
   dif_R=abs(R_hat-&R);  
   output; 
  end; 
 run; 
 
 data e; set d; if dif_R=. then delete; run; 
 
 proc sort data=e; by dif_R; run; 
 
 data f; set e; 
   if _n_ ne 1 then delete; 
   call symput("K", K);run; 
 run; 
 
 proc print data = f; 
  var K; 
  title ' K_hat at Time &time when beta = 0.95'; 
 run; 
 
 
 /****************************************************************
************************** 
 *****************************************************************
************************** 
 THIS MACRO CREATES TOLERANCE INTERVALS FOR EACH TIME POINT 
 *****************************************************************
************************** 
 *****************************************************************
*************************/ 
 data ti; 
  set c d; 
 
  low_ti = (a+b*&_time)-&K*V; 
  up_ti  = (a+b*&_time)+&K*V; 
 proc sort; by low_ti up_ti;  
 run; 
 
 data tol_int; set ti; 
  if low_ti=. then delete; 
  else if up_ti=. then delete; 
 run; 
 
 proc print data=tol_int; 
  var low_ti up_ti; 
 run; 
 
 run;quit; 
%end;      
%mend; 
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%bigone(0,3,6); * change the value of _time in bigone(_time, _n, 
_TotTimes) to  
                  obtain the values of Kl and the tolerance intervals; 
 
/******************************************************************* 
******************************************************************* 
END GLOBAL MACRO 
******************************************************************* 
*******************************************************************/ 
 
/******************************************************************* 
******************************************************************* 
PLOTS OF TOLERANCE INTERVALS 
******************************************************************* 
*******************************************************************/ 
data TI; 
input t y Jonsson_low Jonsson_high Graybill_low Graybill_high Wilks_low 
Wilks_high y_bar; 
cards; 
0 102.55 97.43 107.66 95.61 109.49 97.7771
 108.834 103.31 
1 102.05 96.94 107.16 95.23 108.87 95.1333 105     
100.07 
3 101.06 95.95 106.16 94.43 107.69 87.8229
 115.06 101.44 
6 99.56 94.41 104.71 92.99 106.13 99.5211 102.912
 101.22 
9 98.07 92.83 103.31 91.29 104.85 84.387 111.296
 97.84  
12 96.58 91.22 101.94 89.39 103.77 83.8237 108.166
 96     
; 
* The following exports the data into microsoft excel; 
ods html file = 'C:\Documents and 
Settings\sanogok\Desktop\THESIS\thesis.xls' ;  
proc print data =TI;  
title 'Tolerance Intervals' ;  
run ;  
ods html close ;  
* The excel statemtents for creating the plot are the following ; 
 
* For y_hat 
=SERIES(Sheet1!$B$1,Sheet1!$A$2:$A$7,Sheet1!$B$2:$B$7,1); 
 
* For Jonsson_low 
=SERIES(Sheet1!$C$1,Sheet1!$A$2:$A$7,Sheet1!$C$2:$C$7,1); 
 
* For Jonsson_high 
=SERIES(Sheet1!$D$1,Sheet1!$A$2:$A$7,Sheet1!$D$2:$D$7,1); 
 
* For Graybill_low 
=SERIES(Sheet1!$E$1,Sheet1!$A$2:$A$7,Sheet1!$E$2:$E$7,1); 
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* For Graybill_high 
=SERIES(Sheet1!$F$1,Sheet1!$A$2:$A$7,Sheet1!$F$2:$F$7,1); 
 
* For y_bar 
=SERIES(Sheet1!$I$1,Sheet1!$A$2:$A$7,Sheet1!$I$2:$I$7,1); 
 
* For Wilks_low 
=SERIES(Sheet1!$G$1,Sheet1!$A$2:$A$7,Sheet1!$G$2:$G$7,5); 
 
* For Wilks_high 
=SERIES(Sheet1!$H$1,Sheet1!$A$2:$A$7,Sheet1!$H$2:$H$7,5); 
 
* t represents the x-asis and y the y-axis; 
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